Drug Profile
Metapneumovirus vaccine - CompuVax
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator CompuVax
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Metapneumovirus infections
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Metapneumovirus-infections in USA
- 15 Aug 2016 Early research in Metapneumovirus-infections in USA (unspecified route)